Fossil Remedies

SEPTEMBER 20, 2019

POPULARIZATION AND FUTURE ASPECTS OF PHARMA FRANCHISE BUSINESS. Are you planning to launch a pharma franchise business? If yes, then it is essential to know everything about its prospects and reasons for its popularity. What are the primary reasons that affect it? Experts say that pharma franchise business is different, and hence, it is all the more important to understand it in detail.

75

75

Fuld

FEBRUARY 18, 2019

Fuld + Company engages with companies that are seeking confidence in their business strategy, including companies in the technology sector. These companies have increasing interest in dissecting how integrating AI tools can be a differentiator in a competitive environment—especially as AI’s role in the workplace remains ambiguous. When it comes to talent acquisition, it’s clear that AI-led hr tech is both helpful and disruptive across the tech sector, particularly in terms of how it can save tim

Compounding 65

Compounding Communication 65

The Digital Apothecary

DECEMBER 30, 2019

Well, 2019 is drawing to a close, and I thought it would be good to give a recap to what I've worked on with The Digital Apothecary this year. Overall, I would say it's been one of my most successful years, with over 40,000 visitors - which as a blog that puts out only a few articles a week - I am quite happy about it. Surprisingly, I have found LinkedIn to be one of my most abundant sources of engagements this year, and I think I will start pushing more content on that side.

52

52

Board Vitals - Pharmacist

DECEMBER 19, 2019

Accruing CME hours is essential to maintain any board certification and license to practice medicine at the nursing, advanced practitioner, or physician level. It isn’t easy. The search for meaningful CMEs is never-ending, but this requirement cannot be ignored. If life has swept you away and you have missed the CME deadline to keep your license current, here are some things you can do.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

DECEMBER 3, 2019

Research from Ashfield Meetings & Events clearly demonstrates that face-to-face meetings and events form a major part of continuing medical education (CME). National and international congresses have been identified as the primary event to attend by HCPs. But what makes congresses such a valuable education channel for time-restricted physicians? This pharmaphorum webinar, in association with Ashfield Meetings & Events, will dive into a unique study of HCP educational and behavioural preferences

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Nontraditional Pharmacist

NOVEMBER 20, 2019

Will Soliman, Chairman and CEO, of Accreditation Council for Medical Affairs (ACMA) discusses the exciting opportunities available to pharmacists in the pharma industry and how to pursue them. Name: William Soliman. Title: Chairman, Accreditation Council for Medical Affairs (ACMA). Program: Board Certified Medical Affairs Specialist (BCMAS). Interview Summary.

Communication 52

Communication 52

Med Ed 101

DECEMBER 29, 2019

From the very beginning of Meded101 and Real Life Pharmacology, my goal has been to educate as many healthcare professionals as possible about medication safety. I’m continuing that theme with my latest project, and I want to give it away to you as cheap as Amazon will let me. My latest creation took about 6 […]. The post New Release! 200+ Page Drug Interaction Book for Virtually Nothing… appeared first on Med Ed 101.

40

40

Fossil Remedies

OCTOBER 23, 2019

STEPS TO START A PHARMACEUTICAL DISTRIBUTION COMPANY. When the pharma secto r is touching new heights year after year, it is a great idea to take the business benefits from it. Due to technological and scientific advances, pharmaceutical innovations are happening every second day. It means the opportunities are more than ever, especially if you are an enthusiastic entrepreneur.

67

67

Fuld

SEPTEMBER 16, 2019

Kimberlee Luce has more than 20 years of experience in business research and consulting and has a unique blend of expertise rooted in opportunity analysis, competitor strategy and building effective distribution models in highly fragmented markets. She has provided market and competitive intelligence to some of the world’s largest and most ambitious companies taking her to places as diverse as Peru, Nigeria and China.

Documentation 61

Documentation 61

Fuld

APRIL 24, 2019

Diane Borska, CEO and President, maintains a deep history working with Fuld + Company and has held a variety of positions within the firm spanning an almost 20-year tenure. Over the course of her career, she’s crystalized her values and emphasizes mentoring, problem-solving and client-service which is demonstrated in her leadership style. We sat down with Diane to learn more about her background, her approach to client service, and her take on Fuld + Company’s key differentiators.

61

61

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fossil Remedies

JULY 18, 2019

ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Many people know that the third-party business model gives you a chance to manufacture the products even if you do not have adequate finance. However, it is not the only thing that makes it a successful model.

Pharmaceutical Companies 60

Pharmaceutical Companies Pharmaceutical Companies 60

Fuld

SEPTEMBER 23, 2019

Background + Challenge. An international consumer goods company engaged Fuld + Company to determine the market size and assess marketplace dynamics in a large European country in support of a potential investment by leveraging unique methodology including on the ground field research. The client was unable to use syndicated research for their product in this particular country because the product is sold through traditional trade outlets like corner stores and small shops as opposed to modern tr

58

58

Fuld

MAY 29, 2019

We Debunk 3 Popular Myths Amidst an International Race to 5G. As the pace of disruption increases , Fuld + Company acutely monitors disruptors with the power to upend a variety of industries, especially those that bring immense transformation on a global scale. While most believe groundbreaking innovations have the potential to cause global disruption, the truth is, there are a lot of factors for the public to consider before determining global disruption will take place.

Communication 58

Communication 58

pharmaphorum

NOVEMBER 28, 2019

Pharmaceutical companies spend a huge amount of time and resources on creating valuable brand strategies, but when they come to life there’s often a disconnect. Strategy and execution can easily drift apart when tactics come to life, making it harder for them to drive business and deliver on the long-term action plans to engage with healthcare professionals.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fuld

NOVEMBER 26, 2019

Michael Ratcliffe brings both deep industry expertise and intelligence and strategy consulting capabilities to the firm. Boston, Mass. November 26, 2019 — Fuld + Company, a global competitive strategy consultancy, today announced the recent appointment of Michael Ratcliffe as a Senior Director and Head of the Health & Life Sciences Practice.

Insurance 52

Insurance 52

Fossil Remedies

NOVEMBER 21, 2019

What is the difference between the pharma sector and other sectors? Experts rate the pharma sector quite higher than others because of its huge potential for growth. Because of the tremendous progress in the Indian economy, every pharma company can expect good earnings. However, it is also essential to know about the ways of expanding and popularizing the business.

Documentation 52

Documentation 52

SingleCare

NOVEMBER 6, 2019

If you don’t have it yourself, you probably know at least one person living with diabetes. More than 37 million people in the U.S. alone have the condition. Whether you take prescription medications or not, you’re likely familiar with the hassle of having to monitor your blood glucose levels at all times. The process involves pricking your finger tip with a needle to test a drop of blood—ouch!

Insurance 52

Insurance Dosage Vaccines FDA 52

SingleCare

OCTOBER 31, 2019

We all know that feeling when your favorite local spot shuts down. Whether it’s a restaurant, a clothing store, or a Blockbuster that shutters, it’s disorienting when going there is part of your routine. And it feels even more jarring when it’s a pharmacy that closes its doors. In addition to having familiar faces, your pharmacy provided you with medication and advice, which are crucial parts of staying healthy.

Communication 52

Communication Insurance 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Nontraditional Pharmacist

OCTOBER 14, 2019

Kim Tran’s participation with TNP shows how taking advantage of a networking opportunity can lead to making great connections. You never know where a simple conversation will take you! Name : Kim Tran. Position: Pharmacy Student at Oregon State University. Interview Summary. Kim [00:00:00] Hi everyone and this is Kim Tran. I am a PharmD, MBA candidate at Oregon State University and you are listening to The Nontraditional Pharmacist.

Communication 52

Communication Patient Care Community Pharmacies Pharmaceutical Companies 52

The Digital Apothecary

OCTOBER 4, 2019

Why Digital Health is Key for Pharmacy. And our current pursuits are just not enough. If you have been following my work, you are well aware of my passion and dedication towards getting pharmacists aware of digital health and its implications for future health practice. However, in all honesty, I think I have seen little takeoff amongst the profession by and large, and it has led me to question why that is, so let me break down my current thought process.

Grocery Stores 52

Grocery Stores Independent Pharmacies Community Pharmacies Patient Care 52

The Nontraditional Pharmacist

SEPTEMBER 9, 2019

Dr. Qureshi expands our understanding of the typical Medical Science Liaison role by taking a look at his position in managed markets. Great feature for those considering industry as a career option! Name: Nabeel Qureshi. Title: Medical Liaison, Managed Markets. Interview Summary. Matt [00:00:00] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network.

Specialty Pharmacies 52

Specialty Pharmacies Labelling Patient Care Hospitals 52

pharmaphorum

SEPTEMBER 2, 2019

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing environment in Europe has become increasingly challenging over the years. Innovative contracting has since become a common route to overcome these challenges and ensure timely access for patients. Focus Join us on Monday 2nd September from 15:00-16:00 BST as we discuss the future of innovative contracting with our panel of European payers.

52

52

The Nontraditional Pharmacist

AUGUST 19, 2019

Dr. David Vu innovates by using formal pharmacy training to bring additional value to roles that span other industries. Name: David Vu. Position: QA Engineer + Project Manager at Kit Check. Interview Summary. Matt [00:00:00] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network. Boy we have a great show today. Special guest, David Vu, is joining The Nontraditional Pharmacist show today and he’s a great TNP guest for a couple of reasons.

Controlled Substances 52

Controlled Substances Hospitals 52

pharmaphorum

JULY 23, 2019

Overview Join our live webinar taking place on Tuesday 23rd July at 16:00 BST / 11:00 EST / 08:00 PST. Customer journeys in pharma are changing, with important implications for the marketing supply chain. How can pharmaceutical marketers capitalise on this trend and free up budget to invest in additional marketing channels? Focus New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Nontraditional Pharmacist

JULY 15, 2019

Two Pharmacy Podcast Network podcasters. Two advocates for nontraditional pharmacy. Two powerhouse women pharmacists. One great TNP feature! Name: Ashlee Klevens Hayes. Position: Founder of RxAshlee. Interview Summary. Lynn [00:00:00] Lynn Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network. Today we’re joined by Ashlee Klevens Hayes and I personally have been looking forward to this interview for quite some time.

Hospitals 52

Hospitals Patient Care 52

The Digital Apothecary

JULY 8, 2019

Lofree Calculator. A quick review. Recently I backed Lofree wireless calculator on Kickstarter. Though I’d do a small review while waiting for other videos to be compressed for my digital health stuff.

52

52

The Nontraditional Pharmacist

JUNE 26, 2019

One of our most unique students yet… From the spotlight of performing to the pharmacy, Adam Baillio balances work and time with his (large) family. Name: Adam Baillio. Position: Pharmacy Student at Roseman University. Interview Summary. Matt [00:00:04] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network here with Adam Baillio of Roseman University today on The Nontraditional Pharmacist Student Series.

Compounding Pharmacies 52

Compounding Pharmacies Packaging Compounding Hospitals 52

pharmaphorum

JUNE 13, 2019

Launching orphan medicines excellently will become even more important over the next five years as more patients with rare diseases have pharmacotherapies available. There are also a growing number of disease-focussed registries, increasing public and policy maker awareness, and significant R&D investment in orphan drugs, as well as in digital technologies to support trials and treatment.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Nontraditional Pharmacist

MAY 12, 2019

We’ve all answered the same question at some point – “Why do you want to go to pharmacy school?” Most of the time the answer is what we think interviewers want to hear. But we all know some of the real reasons… We chat with Aleksey on some of these unspoken truths. Name: Aleksey Gitelson. Position: Pharmacy Student at Wilkes University.

Community Pharmacies 52

Community Pharmacies Insurance Hospitals 52

The Nontraditional Pharmacist

APRIL 29, 2019

Some people run from politics while others take the challenges head on. John Scheper looks to management as a springboard into his future campaign trail. Name : John David Scheper. Position: P4 Student at Presbyterian College School of Pharmacy. Interview Summary. Matt [00:00:05] Matt Paterini here with The Nontraditional Pharmacist, part of The Pharmacy Podcast Network.

Hospitals 52

Hospitals 52

The Digital Apothecary

APRIL 26, 2019

We Need to Think Beyond the Fill. Let me preface this by saying this post is more geared towards those outside of the pharmacy space, and wondering how to get into a potentially lucrative business area. After all, the $1 Billion PillPack acquisition by Amazon and their recent outreach to Prime members has caused quite the hubbub in the health sector.

Communication 52

Communication Packaging Patient Care Hospitals 52

pharmaphorum

MARCH 21, 2019

Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab). The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market. Although there are only two drugs in this class available in the region – Eli Lilly’s Olumiant (baricitinib) and Pfizer’s Xeljanz (tofacitinib) – this is not likely to be th

52

52

pharmaphorum

FEBRUARY 7, 2019

Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the second Life Sciences Sector Deal and the long-term plan for the NHS. With these two plans in place there are plenty of opportunities for the industry and the government to work together to keep the UK at the top of the international life sciences sector – and perhaps reach even greater heights.

52

52